Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Trimetazidine dihydrochloride

Trimetazidine dihydrochloride
Trimetazidine dihydrochloride (Vastarel F) can improve myocardial glucose utilization by inhibiting fatty acid metabolism. Trimetazidine is the first cytoprotective anti-ischemic agent, also used as a vasodilator in ischemic heart disease or angina.
Catalog No. T0988Cas No. 13171-25-0
Select Batch
Purity:99.31%
Contact us for more batch information
Resource Download

Trimetazidine dihydrochloride

Catalog No. T0988Cas No. 13171-25-0
Trimetazidine dihydrochloride (Vastarel F) can improve myocardial glucose utilization by inhibiting fatty acid metabolism. Trimetazidine is the first cytoprotective anti-ischemic agent, also used as a vasodilator in ischemic heart disease or angina.
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
Pack SizePriceAvailabilityQuantity
25 mg$34In Stock
50 mg$47In Stock
100 mg$68In Stock
500 mg$165In Stock
1 mL x 10 mM (in DMSO)$30In Stock
Bulk & Custom
Add to Cart

Related Compound Libraries of "Trimetazidine dihydrochloride"

Product Introduction

Bioactivity
Description
Trimetazidine dihydrochloride (Vastarel F) can improve myocardial glucose utilization by inhibiting fatty acid metabolism. Trimetazidine is the first cytoprotective anti-ischemic agent, also used as a vasodilator in ischemic heart disease or angina.
Targets&IC50
Long-chain 3-ketoacyl thiolase (mitochondrial):75 nM
In vitro
Trimetazidine up-regulates miR-21 expression, then miR-21 targets PTEN increasing the PI3K pathway and finally the activation of this pathway counteracts the apoptotic effect of hypoxia/reperfusion[3].
In vivo
The administration of TMZ reduces myocardial infarction size in WT C57BL/6J hearts. Both AMPK and ERK signaling pathways mediate the cardioprotection of TMZ against ischemic injury. Trimetazidine Shifts Metabolism from Fatty Acid Oxidation to Glucose Oxidation and improves Contractile Functions of Cardiomyocytes during Hypoxia[2].
Cell Research
The H9C2 cells are randomly assigned into three groups: Sham group, in which the cells are treated with 0μM TMZ for 48 h and then cultured under normal oxygenation conditions (5% CO2, and 95% air); H/R group, in which cells are treated with 0 μM TMZ for 48 h and then cultured under H/R conditions; and H/R+TMZ group, in which cells are treated with 10 μM TMZ for 48 h and then subjected to H/R treatment. (Only for Reference)
AliasYoshimilon, Kyurinett, Vastarel F
Chemical Properties
Molecular Weight339.258
FormulaC14H24Cl2N2O3
Cas No.13171-25-0
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 65 mg/mL (191.59 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9476 mL14.7380 mL29.4761 mL147.3805 mL
5 mM0.5895 mL2.9476 mL5.8952 mL29.4761 mL
10 mM0.2948 mL1.4738 mL2.9476 mL14.7380 mL
20 mM0.1474 mL0.7369 mL1.4738 mL7.3690 mL
50 mM0.0590 mL0.2948 mL0.5895 mL2.9476 mL
100 mM0.0295 mL0.1474 mL0.2948 mL1.4738 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Trimetazidine dihydrochloride | purchase Trimetazidine dihydrochloride | Trimetazidine dihydrochloride cost | order Trimetazidine dihydrochloride | Trimetazidine dihydrochloride chemical structure | Trimetazidine dihydrochloride in vivo | Trimetazidine dihydrochloride in vitro | Trimetazidine dihydrochloride formula | Trimetazidine dihydrochloride molecular weight